SPA MEDICAL PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: M81047 | DROITWICH, WR9 8RD
Showing results 51-100 of 591
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hydrocortisone | 826 | 25.8K | £5.8K | +84.2% ▲ |
| Bendroflumethiazide | 807 | 46.2K | £737 | +4.3% ▲ |
| Ibuprofen | 795 | 84.8K | £2.0K | +56.3% ▲ |
| Other emollient preparations | 789 | 512.0K | £6.3K | +31.4% ▲ |
| Folic acid | 773 | 37.8K | £799 | -40.4% ▼ |
| 749 | 85.3K | £2.5K | +170.9% ▲ | |
| Alendronic acid | 731 | 5,088 | £1.4K | -2.6% ▼ |
| Desogestrel | 730 | 90.8K | £2.5K | +84.2% ▲ |
| Alginic acid compound preparations | 725 | 402.6K | £5.9K | +23.8% ▲ |
| Duloxetine hydrochloride | 701 | 26.4K | £1.8K | +10.3% ▲ |
| Carbocisteine | 696 | 135.9K | £3.6K | +30.4% ▲ |
| Mometasone furoate | 694 | 800 | £6.2K | +72.9% ▲ |
| Nitrofurantoin | 683 | 9,692 | £4.8K | +43.1% ▲ |
| Sildenafil (Erectile Dysfunction) | 683 | 6,250 | £866 | +35.5% ▲ |
| Flucloxacillin sodium | 668 | 27.8K | £1.5K | +48.6% ▲ |
| Betamethasone valerate | 657 | 60.0K | £3.4K | +70.6% ▲ |
| 657 | 7,715 | £3.1K | +163.3% ▲ | |
| Finasteride | 620 | 31.6K | £1.1K | -5.3% ▼ |
| Lercanidipine hydrochloride | 618 | 34.6K | £3.7K | +0.0% vs avg |
| 617 | 1,926 | £1.0K | +180.0% ▲ | |
| Quetiapine | 604 | 30.4K | £6.2K | -3.0% ▼ |
| Doxycycline hyclate | 587 | 8,517 | £786 | +14.5% ▲ |
| 579 | 83.4K | £3.9K | +22.0% ▲ | |
| Docusate sodium | 573 | 62.9K | £4.4K | +54.6% ▲ |
| Pravastatin sodium | 571 | 29.2K | £1.3K | +75.8% ▲ |
| Indapamide | 560 | 30.2K | £842 | -35.1% ▼ |
| Edoxaban | 560 | 27.2K | £45.2K | -20.1% ▼ |
| Montelukast | 560 | 22.6K | £1.2K | -18.2% ▼ |
| Digoxin | 544 | 24.7K | £1.8K | +43.7% ▲ |
| Insulin glargine | 544 | 3,062 | £30.1K | +91.6% ▲ |
| Perindopril erbumine | 536 | 27.9K | £2.1K | +1.0% vs avg |
| Gliclazide | 536 | 61.4K | £2.2K | -37.0% ▼ |
| 531 | 1,918 | £69.8K | -2.6% ▼ | |
| Latanoprost | 523 | 12.5K | £4.2K | +7.7% ▲ |
| Empagliflozin | 514 | 27.0K | £33.5K | -17.9% ▼ |
| Methylphenidate hydrochloride | 500 | 23.3K | £17.7K | +93.6% ▲ |
| Methotrexate | 498 | 10.3K | £8.6K | +53.0% ▲ |
| Estriol | 497 | 10.0K | £4.9K | +133.6% ▲ |
| Rosuvastatin calcium | 496 | 28.2K | £825 | -44.7% ▼ |
| Insulin aspart | 487 | 3,279 | £21.5K | +27.9% ▲ |
| Fexofenadine hydrochloride | 483 | 26.9K | £1.3K | -43.2% ▼ |
| Mebeverine hydrochloride | 482 | 60.0K | £4.6K | +55.2% ▲ |
| Olanzapine | 480 | 11.4K | £1.5K | +29.6% ▲ |
| Spironolactone | 477 | 20.0K | £1.7K | -11.5% ▼ |
| Sodium valproate | 467 | 78.1K | £8.6K | +46.8% ▲ |
| Lamotrigine | 459 | 30.1K | £4.2K | -22.3% ▼ |
| Solifenacin | 459 | 25.8K | £1.7K | -3.8% ▼ |
| Isosorbide mononitrate | 457 | 25.5K | £2.3K | -30.9% ▼ |
| 453 | 499 | £2.6K | +91.8% ▲ | |
| Sumatriptan succinate | 452 | 5,114 | £3.0K | +27.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.